Reduced androgen levels in adult Turner syndrome: Influence of female sex steroids and growth hormone status

Clinical Endocrinology

Volumn 50, Issue 6, 1999, Pages 791-800

  Gravholt, Claus Højbjerg ^a   Svenstrup, Birgit ^b   Bennett, Paul ^b   Christiansen, Jens Sandahl ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GROWTH HORMONE; NORETHISTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT OUTCOME; TURNER SYNDROME;

ADULT; ANDROGENS; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FOLLICULAR PHASE; GONADAL STEROID HORMONES; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; NORETHINDRONE; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TURNER SYNDROME;

EID: 0033055201     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00720.x     Document Type: Article

References (58)

1. Abraham, G.E. & Maroulis, G.B. (1975) Effect of exogenous estrogen on serum pregnenolone, cortisol, androgens in postmenopausal women. Obstetrics and Gynecology, 45, 271-274.
2. Albright, F., Smith, P.H. & Fraser, R. (1942) A syndrome characterized by primary ovarian insufficiency and decreased stature. Report of 11 cases with a digression on hormonal control of axillary and pubic hair. American Journal of Medical Science, 204, 625-648.
3. Apter, D., Lenko, H.L., Perheentupa, J., Soderholm, A. & Vihko, R. (1982) Subnormal pubertal increases of serum androgens in Turner's syndrome. Hormone Research, 16, 164-173.
4. Brown, D.M., Jowsey, J. & Bradford, D.S. (1974) Osteoporosis in ovarian dysgenesis. Journal of Pediatrics, 84, 816-820.
5. Buckler, H.M., McElhone, K., Durrington, P.N., MacKness, M.I., Ludlam, C.A. & W.U.F.C. (1998) The effects of low-dose testosterone treatment treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women. Clinical Endocrinology, 49, 173-178.
6. Byrne, G.C., Perry, Y.S. & Winter, J.S. (1986) Steroid inhibitory effects upon human adrenal 3 beta-hydroxysteroid dehydrogenase activity. Journal of Clinical Endocrinology and Metabolism, 62, 413-418.
7. Carr, B.R., Breslau, N.A., Givens, C., Byrd, W., Barnett, H.C. & Marshburn, P.B. (1995) Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutisim: a clinical research center study. Journal of Clinical Endocrinology and Metabolism, 80, 1169-1178.
8. Chetkowski, R.J., Meldrum, D.R., Steingold, K.A., Randle, D., Lu, J.K., Eggena, P., Hershman, J.M., Alkjaersig, N.K., Fletcher, A.P. & Judd, H.L. (1986) Biologic effects of transdermal estradiol. New England Journal of Medicine, 314, 1615-1620.
9. Ellison, J.W., Wardak, Z., Young, M.F., Robey, P.G., Laig-Webster, M. & Chiong, W. (1997) PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Human Molecular Genetics, 6, 1341-1347.
10. Fryburg, D.A., Weltman, A., Jahn, L.A., Weltman, J.Y., Samojlik, K., Hintz, R.L. & Veldhuis, J.D. (1997) Short-term modulation of the androgen milieu alters pulsatile, but nor exercise-or growth hormone (GH) -releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes. Journal of Clinical Endocrinology and Metabolism, 82, 3710-3719.
11. Frystyk, J., Skjaerbaek, C., Dinesen, B. & Ørskov, H. (1994) Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Letters, 348, 185-191.
12. Giustina, A., Scalvini, T., Tassi, C., Desenzani, P., Poiesi, C., Wehrenberg, W.B., Rogol, A.D. & Veldhuis, J.D. (1997) Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. Journal of Clinical Endocrinology and Metabolism, 82, 1210-1219.
13. Goodman Gruen, D. & Barrett Connor, E. (1997) Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. American Journal of Epidemiology, 145, 970-976.
14. Gravholt, C.H. & Naeraa, R.W. (1997) Reference values for body proportions and body composition in adult women with Turner's syndrome. American Journal of Medical Genetics, 72, 403-408.
15. Gravholt, C.H., Naeraa, R.W., Frisker, S. & Christiansen, J.S. (1997) Body composition and physical fitness are major determinants of the growth hormone-IGF axis aberrations in adult Turner syndrome, with important modulations by treatment with 17-beta-estradiol. Journal of Clinical Endocrinology and Metabolism, 82, 2570-2577.
16. Gravholt, C.H., Juul, S., Naeraa, K.W. & Hansen, J. (1998) Morbidity in Turner syndrome. Journal of Clinical Epidemiology, 51, 147-158.
17. Gupta, D. & Zimprich, H. (1970) Steroid excretion patterns in children with gonadal dysgenesis (report of 11 cases). Clinica Chimica Acta, 27, 281-288.
18. Hacusler, G., Schmitt, K., Blumel, P., Plochl, E., Waldhor, T. & Frisch, H. (1996) Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height. Acta Paediatrica, 85, 1408-1414.
19. Heitmann, B.L. (1990) Prediction of body water and fat in adult Danes from measurement of electrical impedance. A validation study. International Journal of Obesity, 14, 789-802.
20. Hilding, A., Brismar, K., Degerblad, M., Thoren, M. & Hall, K. (1995) Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. Journal of Clinical Endocrinology and Metabolism, 80, 2646-2652.
21. Ho, K.Y., Evans, W.S., Blizzard, R.M., Veldhuis, J.D., Merriam, G.R., Samojlik, E., Furlanetto, R., Rogol, A.D., Kaiser, D.L. & Thomer, M.O. (1987) Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. Journal of Clinical Endocrinology and Metabolism, 64, 51-58.
22. Ho, K.K. & Weissberger, A.J. (1992) Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism. Journal of Bone Mineral Research, 7, 821-827.
23. Hoffenberg, R. & Jackson, W.P.U. (1957) Gonadal dysgenesis: modern concepts. British Medical Journal, 2, 1457-1462.
24. Iranmanesh, A., Lizarralde, G. & Veldhuis, J.D. (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism. 73, 1081-1088.
25. Jørgensen, J.O., Vahl, N., Hansen, T.B., Skjaerbaek, C., Fisker, S., Ørskov, H., Hagen, C. & Christiansen, J.S. (1998) Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects. Clinical Endocrinology, 48, 479-486.
26. Joss, E.E., Mullis, P.E., Werder, E.A., Partsch, C.J. & Sippell, W.G. (1997) Growth promotion and Turner-specific bone age after therapy with growth hormone and in combination with oxandrolone: when should therapy be started in Turner syndrome? Hormone Research, 47, 102-109.
27. Kaunitz, A.M. (1997) The role of androgens in menopausal hormonal replacement. Endocrinology and Metabolism Clinics of North America, 26, 391-397.
28. Keenan, B.S., Richards, G.E., Mercado, M., Dallas, J.S., Eakman, G.D. & Baumann, G. (1996) Androgen regulation of growth hormone binding protein. Metabolism, 45, 1521-1526.
29. Lee, P.A., Kowarski, A., Migeon, C.J. & Blizzard, R.M. (1975) Lack of correlation between gonadotropin and adrenal androgen levels in agonadal children. Journal of Clinical Endocrinology and Melabolism, 40, 664-669.
30. Lemus, A.E., Enriquez, J., Garcia, G.A., Grillasca, I. & Perez Palacios, G. (1997) 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency. Journal of Steroid Biochemistry and Molecular Biology, 60, 121-129.
31. Lu, P.W., Cowell, C.T., Jimenez, M., Simpson, J.M. & Silink, M. (1991) Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome. Archives of Diseases of Childhood, 66, 1184-1190.
32. Lykkesfeldt, G., Bennett, P., Lykkesfeldt, A.E., Micic, S., Møller, S. & Svenstrup, B. (1985) Abnormal androgen and oestrogen metabolism in men with steroid sulphatase deficiency and recessive X-linked ichthyosis. Clinical Endocrinology, 23, 385-393.
33. Massarano, A.A., Brook, C.G., Hindmarsh, P.C., Pringle, P.J., Teale, J.D., Stanhope, R. & Preece, M.A. (1989) Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol. Archives of Diseases of Childhood, 64, 587-592.
34. Orentreich, N., Brind, J.L., Rizer, R.L. & Vogelman, J.H. (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. Journal of Clinical Endocrinology and Metabolism, 59, 551-555.
35. Park, E. (1977) Body shape in Turner's syndrome. Human Biology, 49, 215-223.
36. Pfeilschifter, J., Scheidt Nave, C., Leidig Bruckner, G., Woitge, H.W., Blum, W.F., Wuster, C., Haack, D. & Ziegler, R. (1996) Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50-to 80-year-old men and women. Journal of Clinical Endocrinology and Metabolism, 81, 2534-2540.
37. Poehlman, E.T. & Copeland, K.C. (1990) Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. Journal of Clinical Endocrinology and Metabolism, 71, 1468-1473.
38. Ranke, M.B., Blum, W.F., Haug, F., Rosendahl, W., Attanasio, A., Enders, H., Gupta, D. & Bierich, J.R. (1987) Growth hormone, somatomedin levels and growth regulation in Turner's syndrome. Acta Endocrinologica, 116, 305-313.
39. Rao, E., Weiss, B., Fukami, M., Rump, A., Niesler, B., Mertz, A., Muroya, K., Binder, G., Kirsch, S., Winkelmann, M., Nordsiek, G., Heinrich, U., Breuning, M.H., Ranke, M.B., Rosenthal, A., Ogata, T. & Rappold, G.A. (1997) Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nature Genetics, 16, 54-63.
40. Ravaglia, G., Forti, P., Maioli, F., Boschi, F., Bernardi, M., Pratelli, L., Pizzoferrato, A. & Gasbarrini, G. (1996) The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian sludy on healthy free-living over-ninety-year-olds. Journal of Clinical Endocrinology and Metabolism, 81, 1173-1178.
41. Reiter, J.C., Craen, M. & Van Vliet, G. (1991) Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity. Acta Endocrinologica, 125, 38-42.
42. Rosenberg, M.J., King, T.D. & Timmons, M.C. (1997) Estrogenandrogen for hormone replacement. A review. Journal of Reproduction Medicine, 42, 394-404.
43. Rosenfeld, R.G., Attie, K.M., Frane, J., Brasel, J.A., Burstein, S., Cara, J.F., Chernausek, S., Gotlin, R.W., Kuntze, J., Lippe, B.M., Mahoney, C.P., Moore, W.V., Saenger, P. & Johanson, A.J. (1998) Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. Journal of Pediatrics, 132, 319-324.
44. Rudman, D., Kutner, M.H., Rogers, C.M., Lubin, M.F., Fleming, G.A. & Bain, R.P. (1981) Impaired growth hormone secretion in th adult population: relation to age and adiposity. Journal of C inical Investigations, 67, 1361-1369.
45. Saenger, P., Schwartz, E., Wiedemann, E., Levine, L.S., Tsai, M, & New, M.I. (1976) The interaction of growth hormone, somatomedin and oestrogen in patients with Turner's syndrome. Acta Endocrinologica, 81, 9-18.
46. Sklar, C.A., Kaplan, S.L. & Grumbach, M.M. (1980) Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. Journal of Clinical Endocrinology and Metabolism, 51, 548-556.
47. Slayden, S.M., Crabbe, L., Bae, S., Potter, H.D., Azziz, R. & Parker, C.R. (1998) The effect of 17 beta-estradiol on adrenocortical sensitivity, responsiveness, and steroidogenesis in postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 83, 519-524.
48. Slemenda, C., Longcope, C., Peacock, M., Hui, S. & Johnston, C.C. (1996) Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. Journal of Clinical Investigations, 97, 14-21.
49. Stepan, J.J., Musilova, J. & Pacovsky, V. (1989) Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome. Journal of Bone Mineral Research, 4, 193-198.
50. Sylven, L., Magnusson, C., Hagenfeldt, K. & Von Schoultz, B. (1993) Life with Turner's syndrome - a psychosocial report from 22 middle-aged women. Acta Endocrinologica, 129, 188-194.
51. Teller, W.M., Homoki, J., Wudy, S. & Schlickenrieder, J.H. (1986) Adrenarche is dissociated from gonadarche - studies in patients with Turner's syndrome. Acta Endocrinologica, 279 (Suppl.), 232-240.
52. Varrela, J., Vinkka, H. & Alvesalo, L. (1984) The phenotype of 45,X females: an anthropometric quantification. Annals of Human Biology, 11, 53-66.
53. Veldbuis, J.D., Sotos, J.F. & Sherman, B.M. (1991) Decreased metabolic clearance of endogenous growth hormone and specific alterations in the pulsatile mode of growth hormone secretion occur in prepubertal girls with Turner's syndrome. Genentech Collaborative Group. Journal of Clinical Endocrinology and Metabolism, 73, 1073-1080.
54. Veldhuis, J.D., Matzger, D.L., Martha, J.r.P.M., Mauras, N., Keenan, B., Rogol, A.D. & Pincus, S.M. (1997) Estrogen and testosterone, but not a non-aromatizable androgen, direct network integration of the hypothalamo-somatotrope (GH) -IGF-I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. Journal of Clinical Endocrinology and Metabolism, 82, 3414-3420.
55. Weissberger, A.J., Ho, K.K. & Lazarus, L. (1991) Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 72, 374-381.
56. Wit, J.M., Massarano, A.A., Kamp, G.A., Hindmarsh, P.C., Van Es, A., Brook, C.G., Preece, M.A. & Matthews, D.R. (1992) Growth hormone secretion in patients with Turner's syndrome as determined by time series analysis. Acta Endocrinologica, 127, 7-12.
57. Yates, J. & Deshpande, N. (1974) Kinetic studies on the enzymes catalysing the conversion of 17alpha-hydroxyprogesterone and dehydroepiandrosterone to androstenedione in the human adrenal gland in vitro. Journal of Endocrinology, 60, 27-35.
58. Young, J., Couzinet, B., Nahoul, K., Brailly, S., Chanson, P., Baulieu, E.E. & Schaison, G. (1997) Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. Journal of Clinical Endocrinology and Metabolism, 82, 2578-2585.